The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

NEW YORK, Jan. 24, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) (the "Company" or "Hoth Therapeutics"), a biopharmaceutical company, today announced ...

(RTTNews) - Hoth Therapeutics (HOTH), a New York-based biopharmaceutical company, announces IP advancements with expanded patent applications for its therapeutic pipeline. The new patents ...

NEW YORK, Jan. 21, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, proudly announces advancements in its intellectual property portfolio ...

Hoth Therapeutics Inc., a patient-focused biopharmaceutical company, has enhanced its intellectual property portfolio by acquiring and expanding patent applications to its therapeutic pipeline. These ...